A B S T RA C T Atypical cases of heritable hemolytic anemia have been noted that conform clinically and biochemically to anemias of the pyruvatekinase (PK)-deficient type, except for the presence of apparently adequate quantities of erythrocyte-PK activity by the usual assay procedure. Investigations of four such anomalous cases, occurring in two unrelated families, are presented. Erythrocytes contained a kinetically aberrant isozyme of pyruvate kinase (PK2). Michaelis constants for the pathologic isozyme relative to phosphoenolpyruvate were over 10-fold greater than control values, but no kinetic abnormality was evident for the second substrate, adenosine diphosphate. PK2 exhibited a pH optimum almost 1 U lower than the wild enzyme form (PK1). Significant differences were also evident in the functional stabilities of the isozymes. Leuko 
INTRODUCTION
Over 100 documented cases (1, 2) of hemolytic anemia associated with hereditary deficiency of erythrocyte pyruvate kinase (PK) have appeared in the world literature since the original description in 1961 (3) . A pattern of clinical and laboratory features has evolved from these studies which partially characterizes this inborn error of erythrocyte metabolism (4, 5) .
A closely related group of patients has been observed in this laboratory and elsewhere which presents a diagnostic dilemma. Because they so well conform to the accepted criteria, they are suspect as PK-deficiency problems, yet quantitative assays by conventional methods consistently fail to detect significant reductions in erythrocyte enzyme levels and, indeed, PK activity is occasionally greater than in normal cells. These findings have suggested the possible existence of an anomalous kinetic form of PK.
The present report describes four such atypical cases of severe hemolytic anemia occurring in two unrelated families. Erythrocyte PK activity in the propositi, adequate by the usual laboratory assay techniques, was found to, have anomalous kinetics with markedly reduced catalytic rates at low -concentrations of its substrate, phosphoenolpyruvate (PEP). Inhibitors were not demonstrable, and kinetics dependent upon the second substrate, adenosine diphosphate (ADP), were normal. Clinical expression appeared to be contingent upon simultaneous inheritance of a gene causing deficiency of the usual molecular species of PK (here designated PK1), and a gene governing production of the pathologic isozyme (here designated PK2). Both genetic defects were traced through three generations, the defective genes apparently residing on autosomes. Qualitative studies established further distinctions between the isozymes, most notably in regard to pH dependency and functional stabilities.
METHODS

Subjects
Kindred G included three affected siblings. 11-yr old propositus 1, a Caucasian male and the eldest child, was noted to be jaundiced shortly after birth without evidence of fetomaternal incompatibilities. Jaundice persisted for 1 1 months, but exchange transfusion was not deemed necessary. Intermittent episodes of icterus, pallor, and dark urine that lasted 1-3 wk were noted at age 6 months and recurred every 2 wk-2 months. Upper respiratory infections were associated with symptom exacerbations. He was hospitalized initially in January 1960, at 414, yr of age, with marked pallor, icterus, and hepatosplenomegaly. Laboratory studies included a reticulocyte count of 11.41%, negative antiglobulin, acid-hemolysis, and Donath-Landsteiner tests, normal levels of red-cell glutathione, and glucose-6-phosphate dehydrogenase activity, normal erythrocyte' osmotic fragility, and a Dacie type-II autohemolysis pattern.
A diagnosis of congenital nonspherocytic hemolytic anemia was made, and during the next 3 yr transfusions were required every 4-6 months. In January 1964, splenectomy was performed after "chromium cell-survival studies demonstrated splenic sequestration and a to of 20 days (normal, 27-36 days). The gall bladder contained numerous small stones, but a liver biopsy was normal. The spleen was enlarged (340 g) but microscopically showed only dilated congested sinusoids. Since surgery, the patient has not required further transfusions and has maintained hemoglobin between 9 and 10 g/100 ml with reticulocytosis of 10-25%o. He has remained fully active and asymptomatic.
Propositus 2, a 7 yr old female, was not jaundiced during the neonatal period but has always been pale with minimally icteric sclerae. She never required transfusion and has maintained hemoglobin levels between 9 and 10 g/100 ml with reticulocytosis of 5-12%. The spleen was enlarged, extending 3-4 cm below the costal margin.
Except for slight pallor, 3-yr old female propositus 3 was well until 17 months of age, when icterus, lethargy, fever, and splenomegaly were noted. The packed cell volume at that time was 15%, and results of autohemolysis, osmotic fragility and other peripheral blood studies were similar to those of her older brother. Transfusions every 4-6 months have maintained her packed cell volume between 21 and 31%.
The fourth sibling, a 9 yr old female, and the parents and grandparents have been clinically and hematologically normal. There is no known consanguinity. The father is of English-Welsh descent, although the surname may have Norman origins. The mother is of northern German and English ancestry. The family has lived in upper New Yprk State since the early 19th century, and all living members reside within a radius of 50 miles.
Kindred D contained one affected child. Propositus 4, a 16 yr old Caucasian male, was the product of a normal pregnancy and delivery but was jaundiced at birth. Although investigations for blood-group incompatibilities were negative, an exchange transfusion was performed. The patient remained chronically anemic thereafter with splenomegaly, reticulocytosis, and elevated serum bilirubin. Spherocytes were not evident in peripheral blood smears, and the incubated red-cell fragility test was normal. Jaundice fluctuated, being transiently worse with viral infections, but transfusions were never required.
For several years he had occasional bouts of vague right upper abdominal pain lasting several days. Initial cholecystograms were negative, but gallstones were noted on films taken in October 1966. Elective cholecystectomy and splenectomy were performed 2' months later. Preoperative physical examination was unremarkable except for jaundice and a firm spleen palpable 6 cm below the costal margin. Total serum bilirubin was 8.6 mg/100 ml (normal, 0-1.0 mg/100 ml) of which 0.7 mg/100 ml was direct reacting (normal, 04.25 mg/100 ml), and the reticulocyte count was 9.3%. Gallstones were present in the cystic duct and gall bladder. Common duct exploration was carried out, and a 973 g spleen was removed.
There was a pronounced postoperative drop in total serum bilirubin to 1.2 mg/100 ml (0.4 mg/100 ml direct reacting) and a rise in the reticulocyte count to a maximum of 25%. Reticulocytes gradually declined to preoperative levels, and hemoglobin values rose to 13 g/100 ml 2-3 months after surgery. This was not sustained and by the 6th postoperative month, serum bilirubin had again risen to values approaching preoperative levels. His condition has since remained stable and transfusions have not been necessary. The parents, both of English extraction, and two male siblings were clinically normal. None of the maternal or paternal relatives was known to be affected. There was no consanguinity nor known relationship to kindred G.
Procedures
Routine hematologic studies were performed by standard methods (6 Bartlett (10) . Methods for the measurement of glucose utilization, lactate production, and ATP stability have been detailed in a previous report (11) .
Enzyme activities in erythrocytes and leukocytes were determined on homogenates of saline-washed cells separated by sedimentation in polyvinylpyrrolidone-citrate and counted in quadruplicate as described previously (12) . Pyruvate kinase was assayed by a modification of the method of Bucher and Pfleiderer (13) , which has been detailed in earlier reports (12, 14) . All (20) .
Michaelis constants (Kin) were determined by simultaneous analyses of erythrocyte and leukocyte PK activities in the standard assay systems at 12-16 concentrations of substrate varying between 0.01 and 9.0 mmoles/ liter for PEP and between 0.05 and 2.0 mmoles/liter for ADP. Final pH in the reaction system was 6.9 ± 0.1. Variations in PEP levels were performed at a constant ADP concentration, 0.4 mmole/liter, whereas studies on the effect of ADP variations were conducted at 1.5 mM PEP. Potassium and magnesium concentrations were held constant at 75.0 and 8.0 mmoles/liter, respectively, and Km for these ions was not determined. Corrections were always made for reagent-blank activities determined at each substrate concentration. These were found to be relatively independent of substrate levels, varying by no more than plus or minus 50% of the very small standard-assay reagent-blank correction. Additionally, erythrocyte PK activities were corrected for contamination with leukocyte PK on the basis of concurrent whitecell assays at each concentration of PEP and ADP. Substrate concentrations coinciding with half-maximal PK activities were taken directly from best-fit linear coordinate curves, which defined Km with greater reproducibility than did extrapolations of double-reciprocal Lineweaver-Burk plots.
RESULTS
Hematologic studies. Table I presents results of standard hematologic measurements on immediate family members obtained at times of enzyme analyses and averaged over the 1 yr study period. Whereas the propositi exhibited moderate to marked anemia, at least one sibling and both parents in each family appeared normal by conventional criteria, excepting perhaps the mother in kindred G who showed progressive signs of mild anemia as she entered the third trimester of her 5th pregnancy. Leukocyte values ranged within normal limits in all family members studied.
Red-cell morphologic abnormalities were qualitatively comparable among all four propositi and did not vary significantly from the nonspecific changes usually seen in congenital nonspherocytic hemolytic anemias. Slight anisocytosis and poikilocytosis with moderate polychromatophilia and macrocytosis were common features. The latter was reflected by slight alterations in red-cell indices. Variable numbers of irregularly contracted and fragmented cells were present along with occasional target cells. Spherocytes were not evident, and platelets always appeared adequate in quantity. Stained films of peripheral blood and erythrocyte indices from the parents and unaffected siblings appeared normal, again with the exception of the pregnant mother in kindred G, who showed changes compatible with slight hypochromic, normocytic anemia.
Osmotic fragility of fresh erythrocytes was either normal or slightly decreased in all cases studied, and the propositi were indistinguishable on this basis from other family members. Preincubation of blood for 24 hr at 370C effected some deviation from normal fragility patterns.
Onset of propositus-cell hemolysis was either normal (two cases) or occurred at saline concentrations slightly higher than usual (two cases), but the majority of these cell populations showed substantial resistance to osmotic lysis, a characteristic shared by the mother in kindred G. In other family members the patterns of incubated-cell osmotic fragilities were either normal or indicative of slightly increased resistance to osmotic disruption. Studies on the effectiveness of erythrocyte glycolysis. Autohemolysis of sterile defibrinated blood from the propositi was slightly or moderately increased after 48-hr incubation at 370C. Table I shows the extent of this in vitro abnormality and the relative ineffectiveness of glucose and adenosine as corrective agents. In the presence of neutralized ATP, autohemolysis was restored to normal levels in the three cases tested. These findings conformed to the Selwyn-Dacie type-II designation (7), the autohemolysis pattern commonly noted in quantitative PK deficiencies.
Measurements of glucose utilization and lactate production by red cells of kindred G are presented in Table II . The proband generally showed variable increases in both parameters, most likely reflecting the increased metabolic rates of young cell populations. The ratio of lactate production to glucose consumption, more reliable for comparative purposes than either value alone, was in each case within the range of normals.
Erythrocyte ATP stabilities over a 3 hr incubation period are also recorded in Table II for three propositi and their close relatives. Except for the splenectomized patient, propositus 1, who showed a 37% loss of ATP (over a 4 hr period), all were considered to be within normal limits. Additional studies on propositus 3 were expanded to include incubations up to 6 hr. Under these circumstances, intracellular ATP decreased 9.5, 23.5, and 36.3%o after 2, 4, and 6 hr, respectively, indicating that Whereas there were no significant individual deviations from normal controls in red-cell or leukocyte PK Km relative to ADP, marked differences in Km for PEP were found in erythrocytes from the propositi and certain family members. These ranged from 1.2 to 1.6 mmoles/liter for proband cells (Table IV , group 1), reflecting at least a 10-fold elevation over normal values. Studies with white-cell suspensions established that this enzyme aberration was not shared by leukocytes.
Segregation into two distinct molecular species of erythrocyte PK on the basis of kinetic behavior was further supported by the occurrence in 10 family members (Table IV, 
All paternal family members, in addition to some maternal relatives, displayed normal PK kinetics whether or not the individual had absolute erythrocyte activities indicative of a heterozygous PK-deficiency state on a quantitative basis (Table  IV , group 3).
In Fig. 1 , PK activity in propositus hemolysates is shown as a function of PEP concentration, demonstrating markedly reduced catalysis at low substrate levels. At the PEP concentration usually employed in PK assays (in this laboratory, 1.5 mmoles/liter), erythrocyte PK activity of all propositi was normal or slightly subnormal. Km. calculations from these data, however, revealed marked differences in kinetic behavior between normal and propositus enzyme.
To provide a common scale for comparative purposes, the data in Fig. 1 were converted from absolute values to rate-of-change curves in Fig. 2 describing the celerity of approach to maximum PK activities as substrate levels increased. These curves designated the PEP concentrations at which varying fractions of maximal PK activity occurred. Prominent slope differences, most pro- (Table IV) ., supporting the hypothesis that both PK1 and PK2 isozymes were present in these erythrocytes.
In view of the relative lability of PK preparations and the sensitivity of Km (PEP) measurements to assay parameters, direct comparison with Km (PEP) values reported in the literature seems tenuous. Such constants for human erythrocyte PK have been shown to vary with environmental concentrations of magnesium (21) ranges studied or the high magnesium-ion levels employed (21), these findings, if confirmed, would suggest a mechanism of enzymatic conversion possibly different from that suspected to prevail with PK from leukocvtes and other sources (24, 29) . As suggested by the investigators, it would be of particular pertinence to consider this phenomenon in relation to studies with mutant enzyme forms such as PK2. As yet, we have not been able to establish whether this effect is demonstrable with either PK1 or PK2 isozymes under our assay conditions.
Modification of the standard PK assay method. For the patient in each kindred initially studied (propositi 1 and 4), intersection of normal and propositus activity curves in Fig. 1 Deceased individuals and those not studied are noted by diagonal lines and question marks, respectively. A partially blackened symbol indicates heterozygous deficiency for the usual molecular form of erythrocyte pyruvate kinase, PK1. Heterozygosity for the anomalous isozyme, PK2, indicated by partial shading, is isolated to the proband and their siblings and maternal relatives. Position III-2 in kindred G has been filled by the recent birth of a male infant whose cord-blood PK assayed at 1.79 EU with a Km (PEP) of 1.1 mmoles/liter. separate procedures. Lysates were prepared by dilution of saline-washed erythrocytes in 4-9 volumes of 0.005 M phosphate buffer, varying in different experiments from pH 6.6 to 7.6, followed by triplicate freezing and thawing in a Dowanol and dry-ice mixture. Hemolysates (approximately 20 ml) were equilibrated at 40C either by dialysis against large volumes of the appropriate buffer (3-5 liters changed three times over 8 to 12 hr) or by passage through a 1.5 X 25.0-cm column of Sephadex G-25 previously equilibrated with the same buffer. Without exception, PK kinetics in the hemolysates were unaltered by such deionization procedures. Some decrease in total PK activity was occasionally observed after the more prolonged dialyses, but again activities in mixtures were equal to the sums of activities in the unmixed components identically treated.
Studies on pH effects. Erythrocytes from two propositi were studied for pH dependency of their PK activities. Cells from four normal controls and three family members with intermediate kinetics were similarly studied. The assay system was prepared using triethanolamine-HCl (TEA) buffers of identical molarity but varying pH, and pH was determined in each cuvette solution with a Beckman Expandomatic pH meter, both before and after initiation of the enzymatic reaction with hemolysate.
Prevailing pH was found invariably to be lower than that of the primary buffer. It was apparent that the standard assay system, containing TEA in a final concentration of 8.3 mmoles/liter, possessed insufficient buffering capacity to maintain pH at 7.5 as supposed. Actual values ranged between 6.8 and 7.1, the variations occasioned by different batches of PEP.
Results of pH dependency studies, presented in Fig. 7 , indicated that a pH range of 6.8 to 7.1 was still optimal for normal PK1, but PK2 from propositus cells reached peak efficiency between 6.1 and 6.4. Rapid decrescence of PK, activity above pH 6.5 possibly accounted for the several low values noted for some propositi and maternal relatives on the basis of standard PK assays (Table  III and Fig. 1) , some of which would normally be considered indicative of heterozygous PKdeficiency states.
All hemolysates behaved similarly at low pH but showed divergent characteristics above pH 6.0, Values shown in the upper graph were determined at the PEP concentration usually employed in routine PK assays; those in the lower graph were determined simultaneously at a low substrate level. The pH reported is a mean of values determined before initiation and after completion of reaction measurements in each cuvette, a value range of less than 0.05 pH U.
when PEP concentration was 1.5 mmoles/liter. The distinct differences between pH-dependency curves derived for propositus and normal red-cell PK were accompanied again by intermediate curves in three cases postulated to represent coexistence of PK1 and PK2. These distinctions were clear whether or not PK activities were determined at high or low substrate levels. As shown in the lower half of Fig. 7 , differences among the three groups (propositi, intermediates, and normals) at 0.4 mM PEP were apparent over the entire pH range explored.
Comparison of curves in Fig. 7 indicated further that the ratio of activities at these two concentrations was also a dependent variable of pH. Segregation of cases on the basis of activity ratios at high and low PEP levels, as proposed for the modified PK screening test, therefore required critical control of pH to ensure reproducibility as well as validity. PK stability studies. In view of relatively rapid degradation of PK activity in stored erythrocytes, and especially in hemolysates, Attempts were made to detect differences in stability characteristics of PK1 relative to PK2. Saline-washed red cells from normal controls, propositi, and some relatives with intermediate kinetics were stored intact or as phosphate-buffered hemolysates at 22, 4, and -200C. Intact erythrocytes at the latter temperature were frozen rapidly in dry-ice and Dowanol mixtures before storage. PK assays at high and low substrate concentrations were conducted over a 1 month period. Magnesium in conjunction with mercaptoethanol (MCE) was also tested for ability to retard PK inactivation.
Generally, PK2 stability was found to be less than half that of PK, under all comparable storage conditions. Washed-cell preparations showed identical activity losses whether preserved at 4 or -200C. Mean curves presented in Fig. 8 Fig. 9 , which also indicated a greater stabilizing effect by the additives on PK1 than on PK2.
DISCUSSION
Preliminary attempts to obtain isozyme separation by gel filtration, starch-gel electrophoresis, and column chromatography yielded equivocal results at least partially due to instability of this enzyme over the periods required for shipment and processing. Electrophoretic separations were additionally complicated by the lack of a suitable positive stain for PK. Nevertheless, proband erythrocyte PK was found to differ distinctly from the usual enzyme form on the basis of kinetic properties, pH dependency, and functional stability. In the absence of demonstrable inhibitors, these variations, virtually identical in propositi from two unrelated families, seemed sufficient in magnitude to justify the supposition that a pathologic PK isozyme (PK2) was operative in erythrocytes of affected subjects. This supposition was supported by the frequent occurrence of intermediate degrees of variation in phenotypically normal relatives in whom erythrocyte studies indicated coexistence of both isozymes.
The diverse findings in these studies may be reconciled within the framework of a simple unifying hypothesis regarding the patterns of genetic expression in erythrocyte PK deficiency. This hypothesis presumes that erythrocyte-PK activities and kinetics common to most individuals in the population at large should occur when both contributed genes are normal, resulting in a genotype designated PK1PKR.
A gene, here designated PK1A, which produces kinetically normal but quantitatively deficient activity, when inherited in company with a normal PK1 gene, would then effect the common heterozygous deficiency state with normal kinetics but approximately half-normal activity levels, a genotype of PK1PKA. Similarly, the usual homozygous PK deficiency with genotype PK1APKRA should behave normally by kinetic standards if the paucity of enzyme protein permits experimental determinations. We have found this to be true in several cases so studied, as have other investigators (22, 23, 29 In normal erythrocytes, PK activity has been shown to depend directly upon PEP availability, and generally this enzyme operates far below its potential maximum (21) . In PK-deficient cells of the usual variety, the enzyme may be more nearly saturated as PEP concentrations increase due to the partial metabolic block. Concurrently, the fall in intracellular levels of ATP, which partially competes with PEP for a common binding locus (27, 30) , may actually increase rates of PK catalysis in the deficient cell with a consequent Km (PEP) depression (21 (31, 32) .
In the present study, as in many instances of quantitative PK deficiency, glycolysis and ATP maintenance in the cells assayed appeared reasonably adequate. It should be emphasized, however, that in such subjects only select reticulocyte-rich populations of young cells still capable of survival are available for study. In view of the ancillary metabolic pathways available to reticulocytes, the greatly enhanced glycolytic capacities of young erythrocytes compared with older cells, and the fact that all assays yield mean values, such observations fail to answer the crucial question, i.e., how will these same cells glycolyze and maintain ATP at some later stage of existence?
It is clear that capacity for erythrocyte survival in extreme cell youth cannot be extrapolated to older cells, and hemolytic anemia by definition will be the result of diminished survival. Ultimate metabolic aberrations preceding cell destruction may be demonstrable only in moribund cells which are not selectively available for study. Measurements of glycolytic activity, ATP levels and ATP maintenance in cells a priori still capable of survival can only provide hints of metabolic events immediately proximal to cell destruction.
Adequate erythrocyte survival measurements were not available in the present cases, but lifespan shortening may be gauged clinically and in terms of measured elevations in G-6-PD activities and reticulocytes. The etiologic basis of the metabolic findings reported in Table II is thus open to some speculation, and equal argument might be made for an increase in ATP utilization as opposed to impaired formation. Such considerations aside, one point remains clear: the patterns of metabolic changes in propositus erythrocytes, as well as the clinical features presented by the proband, conformed well to those demonstrable in homozygous PK deficiency of the quantitative type.
Chronic hemolytic anemia, then, has been found to be associated both with severe quantitative depression of PK activity and with active enzyme catalytically inefficient at low substrate concentra--tions. This essential identity in phenotypic expression resulting from two separate aberrations in erythrocyte PK renders it unlikely that any mechanism other than deficient PK catalysis' is primary in causing the observed syndrome.
Just as the general category of congenital nonspherocytic hemolytic anemias has been shown to be a heterogeneous group frequently associated with one of several erythroenzymopathies, similar heterogeneity appears to be evolving within the subcategory of PK-deficiency hemolytic anemias. (35) .
Unpublished studies by Miwa, Ohyama, and Kumatori 2 and by Tanaka 3 have also indicated that abnormal PK kinetics rather than a quantitative enzyme deficit may underlie some instances of the syndrome. Tanaka has noted an occasional patient with intermediate levels of red-cell PK activity whose apparent Km (PEP) was over twice normal. In the case investigated by Miwa et al., a child with nonspherocytic hemolytic anemia was found to have elevated erythrocyte levels of PEP and monophosphoglycerates, as well as increased PK activity. The Km (PEP) was five times greater than that of controls, and the pH optimum was also shifted to the acidic region.
There has been justifiable controversy regarding the relative importance of mutant structural-gene vs. control-gene effects in PK-deficiency anemias. The extensive work of Koler et al. (29) , which established the molecular distinction between leukocyte and erythrocyte PK, additionally demonstrated apparent molecular homogeneity of this enzyme within erythrocytes, whether normal, heterozygous, or homozygous for quantitative PK deficiency. In support of the latter findings, kinetic studies of homozygotes by Wiesmann and T6nz (23) and Campos et al. (22) failed to demonstrate significant deviations from normal.
The possibility of mutant structural genes also operating in PK-deficiency states received preliminary support from Waller and L6hr (36, 37) and from Boivin and Galand (38) . Waller and L6hr's two cases had Km (PEP) values in crude hemolysates two to four times higher than normals, but with less than 8%o of the usual measurable activity, in contrast to our observations of 10-fold higher Km associated with borderline normal or elevated activity rates when assayed with 1.5 mm PEP as substrate. Boivin and Galand, working with PK partially purified by diethylaminoethyl (DEAE) extraction and ammonium sulfate precipitation, found Km (PEP) five times lower than normals in red cells having some 20% of the usual activity levels at full enzyme saturation, indicating that in their case, enhanced catalytic efficiency might be possible at low PEP concentrations.
Such diverse observations make it difficult to incriminate either a control-gene or structural-gene mutation alone as the sole genetic determinant of PK-deficiency hemolytic anemia. It would seem more appropriate to postulate that the syndrome may result from a mutant regulator or mutant structural gene, or both in combination, with a greater probability being associated with controlgene defects.
Certainly such conjectures must be considered speculative, not only because alternative explanations exist, but also because some of the published information remains unconfirmed and was reported originally with incomplete specification of assay conditions. Nonetheless, two blocks of reliable data now indicate that familial hemolytic anemia, conforming in virtually all respects to the PK-deficient type, may be associated with either a quantitative or a qualitative enzyme defect, lending a priori support to a basic pathogenetic role for the enzymopathy per se in the induction of premature hemolysis.
